Model‐based meta‐analysis: an important tool for making quantitative decisions during drug development

DR Mould - Clinical Pharmacology & Therapeutics, 2012 - Wiley Online Library
Modeling during drug development is routinely used to integrate subject‐level information,
evaluate response, and inform clinical trials. Model‐based meta‐analysis (MBMA) combines …
被引用次数：90 相关文章

Model-Based Meta-Analysis: An Important Tool for Making Quantitative Decisions During Drug Development.

DR Mould - Clinical Pharmacology & Therapeutics, 2012 - search.ebscohost.com
Modeling during drug development is routinely used to integrate subject-level information,
evaluate response, and inform clinical trials. Model-based meta-analysis (MBMA) combines …

[引用][C] Model-Based Meta-Analysis: An Important Tool for Making Quantitative Decisions During Drug Development

DR Mould - Clinical Pharmacology & Therapeutics, 2012 - cir.nii.ac.jp
Model-Based Meta-Analysis: An Important Tool for Making Quantitative Decisions During
Drug Development | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

Model-based meta-analysis: an important tool for making quantitative decisions during drug development.

DR Mould - Clinical Pharmacology and Therapeutics, 2012 - europepmc.org
Modeling during drug development is routinely used to integrate subject-level information,
evaluate response, and inform clinical trials. Model-based meta-analysis (MBMA) combines …

Model-based meta-analysis: an important tool for making quantitative decisions during drug development

DR Mould - Clinical pharmacology and therapeutics, 2012 - pubmed.ncbi.nlm.nih.gov
Modeling during drug development is routinely used to integrate subject-level information,
evaluate response, and inform clinical trials. Model-based meta-analysis (MBMA) combines …

[引用][C] Model-Based Meta-Analysis: An ImportantTool for Making Quantitative Decisions During Drug Development

DR MOULD - Clinical pharmacology and therapeutics, 2012 - Nature Publishing Group